Pegfilgrastim- versus filgrastim-based autologous hematopoietic stem cell mobilization in the setting of preemptive use of plerixafor: efficacy and cost analysis von Costa, Luciano J., Kramer, Cindy, Hogan, Kathy R., Butcher, Coleen D., Littleton, Amanda L., Shoptaw, Katie B., Kang, Yubin, Stuart, Robert K.

Volltext